OxGene and Native Antigen Company Collaborate to Increase Covid-19 Antigen Production
The shared goal is to deliver high-purity, recombinant proteins for the development of covid-19 diagnostics and vaccines.
Read MorePosted by | Apr 13, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The shared goal is to deliver high-purity, recombinant proteins for the development of covid-19 diagnostics and vaccines.
Read MorePosted by | Apr 8, 2020 | Lung Cancer, Urinalysis & Toxicology |
A noninvasive urine test that can detect the presence of proteins linked to lung cancer could help detect more tumors in the early stages of the disease.
Read MorePosted by | Apr 8, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Computational (in silico) design allows for rapid iteration around potential solutions without the unique variables that traditional in vivo subjects may possess.
Read MorePosted by | Apr 8, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Dozens of laboratories in Africa, Asia, Europe, Latin America, and the Caribbean will receive diagnostic machines and kits, reagents, and laboratory consumables
Read MorePosted by | Apr 7, 2020 | Emerging & Zoonotic Diseases, Infectious Diseases |
The Aries SARS-CoV-2 assay will run on the company’s Aries system, an FDA-cleared, automated molecular diagnostics platform for moderate-complexity labs.
Read More